Interface Biosciences

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2627 Hanover St, Palo Alto, California, ...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Interface Biosciences

Interface Bio is a drug company focused on developing next-generation, multi-targeted immunotherapies to treat complex diseases such as autoimmune disorders and cancer. The company leverages natural products produced by commensal microbes in the human body, utilizing AI-guided search strategies to optimize these therapeutics. Their innovative platform integrates precision culturomics, targeted metabolomics, and molecular engineering to create safe and effective medicines. Interface Bio aims to revolutionize the therapeutic landscape by providing breakthrough solutions with unprecedented stability, potency, and safety.Explore more
Interface Biosciences's Social MediaPopular SearchesInterface BiosciencesSIC Code 28,283NAICS Code 32,325Show more

Interface Biosciences Org Chart

PhoneEmail
DM
United States flag for contact location.

Senior Research Associate

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Interface Biosciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Interface Biosciences

Compare insights from companies similar to Interface Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Interface Biosciences

<$5M
1-10
Private
-
2020
DM
Daniel MummauSenior Research Associate
$10M
11-50
Private
$11.2M
-
$5.3M
11-50
Private
-
2016
N/A
<$5M
11-50
Private
$103M
2020
DB
Dorothy BaileyPresident & Chief Operating Officer
<$5M
1-10
Private
-
2015
Emre Koyuncu, Founder & Chief Executive Officer at Crescenta Biosciences
Emre KoyuncuFounder & CEO
<$5M
1-10
Private
-
2017
RT
Ruhab TahirAccount Manager
<$5M
1-10
Private
-
1999
SR
Stuart RingoldDirector, Operations (North America)
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Interface Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Interface Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Interface Biosciences.

Interface Biosciences Tech Stack

A closer look at the technologies used by Interface Biosciences

Top Manufacturing Companies

Frequently Asked Questions Regarding Interface Biosciences

What is Interface Biosciences's official website?
Interface Biosciences's official website is interface.bio
What is Interface Biosciences's Revenue?
Interface Biosciences's revenue is <$5 Million
What is Interface Biosciences's SIC code?
Interface Biosciences's SIC: 28,283
What is Interface Biosciences's NAICS code?
Interface Biosciences's NAICS: 32,325
How many employees does Interface Biosciences have?
Interface Biosciences has 1-10 employees
What industry does Interface Biosciences belong to?
Interface Biosciences is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Interface Biosciences competition?
Interface Biosciences top competitors include: Exo Therapeutics, Glycominds, Koutif Therapeutics, OROX BioSciences
What technology does Interface Biosciences use?
Some of the popular technologies that Interface Biosciences uses are: WordPress.org, PHP, Google Font API, Microsoft 365
What does Interface Biosciences do?

Interface Bio is a drug company focused on developing next-generation, multi-targeted immunotherapies to treat complex diseases such as autoimmune disorders and cancer. The company leverages natural products produced by commensal microbes in the human body, utilizing AI-guided search strategies to optimize these therapeutics. Their innovative platf... orm integrates precision culturomics, targeted metabolomics, and molecular engineering to create safe and effective medicines. Interface Bio aims to revolutionize the therapeutic landscape by providing breakthrough solutions with unprecedented stability, potency, and safety.Read More

What are Interface Biosciences social media links?
Interface Biosciences Linkedin page Interface Biosciences Twitter page
Is Interface Biosciences a public company?
Interface Biosciences is private company therefore does not currently have an official ticker symbol
See more information about Interface Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.